Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency
Open accessThe DOI matches its Crossref record; 25 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Iron deficiency may impair aerobic performance. This study aimed to determine whether treatment with intravenous iron (ferric carboxymaltose) would improve symptoms in patients who had heart failure, reduced left ventricular ejection fraction, and iron deficiency, either with or without anemia. METHODS: We enrolled 459 patients with chronic heart failure of New York Heart Association (NYHA) functional class II or III, a left ventricular ejection fraction of 40% or less (for patients with NYHA class II) or 45% or less (for NYHA class III), iron deficiency (ferritin level <100 microg per liter or between 100 and 299 microg per liter, if the transferrin saturation was <20%), and a hemoglobin level of 95 to 135 g per liter. Patients were randomly assigned, in a 2:1 ratio, to receive 200 mg of intravenous iron (ferric carboxymaltose) or saline (placebo). The primary end points were the self-reported Patient Global Assessment and NYHA functional class, both at week 24. Secondary end points included the distance walked in 6 minutes and the health-related quality of life. RESULTS: Among the patients receiving ferric carboxymaltose, 50% reported being much or moderately improved, as compared with 28% of patients receiving placebo, according to the Patient Global Assessment (odds ratio for improvement, 2.51; 95% confidence interval [CI], 1.75 to 3.61). Among the patients assigned to ferric carboxymaltose, 47% had an NYHA functional class I or II at week 24, as compared with 30% of patients assigned to placebo (odds ratio for improvement by one class, 2.40; 95% CI, 1.55 to 3.71). Results were similar in patients with anemia and those without anemia. Significant improvements were seen with ferric carboxymaltose in the distance on the 6-minute walk test and quality-of-life assessments. The rates of death, adverse events, and serious adverse events were similar in the two study groups. CONCLUSIONS: Treatment with intravenous ferric carboxymaltose in patients with chronic heart failure and iron deficiency, with or without anemia, improves symptoms, functional capacity, and quality of life; the side-effect profile is acceptable. (ClinicalTrials.gov number, NCT00520780).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, parenteral iron substitution has been found to improve the clinical course of CHF in patients with coexisting ID [22–24].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [24]
In the citing paper
“We are aware that anemia is a complication of iron deficiency, though not the only one, since other tissues/organs may be iron-depleted before anemia develops, as occurs in chronic heart failure.75”
From Iron metabolism and iron disorders revisited in the hepcidin era (2020) · cites this paper as [75]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
EQ-SD: a measure of health status from the EuroQol Group
Rabin, R., & Charro, F. D. (2001) · Annals of Medicine · doi:10.3109/07853890109002087 · Cited by 5,613
Regression Models for Ordinal Data
McCullagh, P. (1980) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1980.tb01109.x · Cited by 4,453
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008
Dickstein, K., Authors/Task Force Members, Cohen-Solal, A., Filippatos, G., McMurray, J. J. V., Ponikowski, P., Poole-Wilson, P. A., Strömberg, A., van Veldhuisen, D. J., Atar, D., et al. (2008) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2008.08.005 · Cited by 3,512
Self-citationGreen, C. P., Porter, C. B., Bresnahan, D. R., & Spertus, J. A. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00531-3 · Cited by 1,827
Trends in Heart Failure Incidence and Survival in a Community-Based Population
Roger, V. L. (2004) · JAMA · doi:10.1001/jama.292.3.344 · Cited by 1,600
Jessup, M., & Brozena, S. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021498 · Cited by 1,564
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.11.013 · Cited by 1,374
Haas, J. D., & Brownlie, T. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.676s · Cited by 1,186
Research works printed but not linked: 4
- Fairbanks V, Beutler E. Iron deficiency. In: Beutler E, ed. Williams hematology. 6th ed. New York: McGraw-Hill, 2001:295-304, 447-70.
- Davies KJ, 1982, Am J Physiol, 242, E418
- Usmanov RI, 2008, J Nephrol, 21, 236
- Ganzoni AM, 1970, Schweiz Med Wochenschr, 100, 301
Cited by
Items 201–300 of 1,002
Iron Deficiency and Risk of Early Readmission Following a Hospitalization for Acute Heart Failure
Núñez, J. E., Colet, J. C., Miñana, G., Núñez, E., Santas, E., Mollar, A., Valero, E., García‐Blas, S., Cardells, I., Bodı́, V., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.513 · Cited by 104
Clinical iron deficiency disturbs normal human responses to hypoxia
Frise, M. C., Cheng, H.-Y., Nickol, A. H., Curtis, M. K., Pollard, K. A., Roberts, D. J., Ratcliffe, P. J., Dorrington, K. L., & Robbins, P. A. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85715 · Cited by 103
Iron Deficiency in Heart Failure
Loncar, G., Obradović, D., Thiele, H., von Haehling, S., & Lainščak, M. (2021) · ESC Heart Failure · doi:10.1002/ehf2.13265 · Cited by 131
Silverberg, D. S., Mor, R., Weu, M. T., Schwartz, D., Schwartz, I. F., & Chernin, G. (2014) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-14-24 · Cited by 113
The impact of anaemia and intravenous iron replacement therapy on outcomes in cardiac surgery
Hogan, M. P., Klein, A. A., & Richards, T. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu200 · Cited by 106
Effect of dapagliflozin on anaemia in DAPA‐HF
Docherty, K. F., Curtain, J. P., Anand, I. S., Bengtsson, O., Inzucchi, S. E., Køber, L., Kosiborod, M., Langkilde, A. M., Martínez, F. A., Ponikowski, P. P., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2132 · Cited by 113
Self-citationBhandari, S., Kalra, P. A., Berkowitz, M. M., Belo, D., Thomsen, L. L., & Wolf, M. S. (2020) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa011 · Cited by 106
Management of iron deficiency anemia in inflammatory bowel disease - a practical approach.
Stein, J. M., & Dignass, A. U. (2013) · PubMed Central · Cited by 127
Wilson, K. C., & Sloan, J. M. (2015) · New England Journal of Medicine · doi:10.1056/nejmc1507104 · Cited by 106
Intravenous iron supplementation therapy
Schaefer, B., Meindl, E., Wagner, S., Tilg, H., & Zoller, H. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100862 · Cited by 129
Iron therapy for preoperative anaemia
Ng, O., Keeler, B. D., Mishra, A., Simpson, J. A., Neal, K. R., Al-Hassi, H. O., Brookes, M., & Acheson, A. G. (2019) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011588.pub3 · Cited by 110
“The use of intravenous iron in anaemic patients with chronic heart failure has been shown to improve symptoms and quality of life significantly (Anker 2009; Okonko 2008).”
BackgroundHawwa, N., Shrestha, K. L., Hammadah, M., Yeo, P. S. D., Fatica, R. A., & Tang, W. H. W. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.08.023 · Cited by 108
Bisbe, E., Moltó, L., Arroyo, R., Muniesa, J. M., & Tejero, M. (2014) · British Journal of Anaesthesia · doi:10.1093/bja/aeu092 · Cited by 105
Martens, P., Dupont, M., Dauw, J., Nijst, P., Herbots, L., Dendale, P., Vandervoort, P. M., Bruckers, L. M., Tang, W. H. W., & Müllens, W. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab411 · Cited by 104
Iron deficiency is associated with adverse outcome in Eisenmenger patients
Bruaene, A. V. D., Delcroix, M., Pasquet, A., Backer, J. F. A. D., Pauw, M. D., Naeije, R., Vachiéry, J.-L., Paelinck, B. P., Morissens, M., & Budts, W. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr130 · Cited by 98
2022 ACC/AHA/HFSA Guideline for the Management of Heart Failure: Executive Summary
Heidenreich, P. A., Bozkurt, B., Aguilar, D. A., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A. M., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2022.02.009 · Cited by 118
Nutrition in Inflammatory Bowel Disease
Schreiner, P., Martinho-Grueber, M., Studerus, D., Vavricka, S. R., Tilg, H., Biedermann, L., & on behalf of Swiss IBDnet, A. O. W. G. O. T. S. S. O. G. (2020) · Digestion · doi:10.1159/000505368 · Cited by 123
Intravenous iron: a framework for changing the management of iron deficiency
Auerbach, M., Gafter‐Gvili, A., & Macdougall, I. C. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30264-9 · Cited by 108
Guedes, M. H., Muenz, D. G., Zee, J., Bieber, B. A., Stengel, B., Massy, Z. A., Mansencal, N., Wong, M., Charytan, D. M., Reichel, H., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020101531 · Cited by 102
von Haehling, S., Doehner, W., Evertz, R., Garfias‐Veitl, T., Derad, C., Diek, M., Karakas, M., Birkemeyer, R., Fillippatos, G., Lainščak, M., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae479 · Cited by 111
“This has led to the conduct of several large-scale trials, 4–6 reinforcing that correcting ID improves quality of life (QoL), enhances exercise capacity, and reduces HF hospitalization rates in patients with HF with reduced ejection fraction (HFrEF) or mildly reduced ejection fraction, leading to…”
BackgroundResultSelf-citationIntravenous iron therapy: how far have we come?
Cançado, R. D., & Muñoz, M. (2011) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.5581/1516-8484.20110123 · Cited by 94
Parikh, A., Natarajan, S., Lipsitz, S. R., & Katz, S. D. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.111.960906 · Cited by 116
Núñez, J. E., Miñana, G., Cardells, I., Palau, P., Llàcer, P., Fácila, L., Almenar, L., López-Lereu, M. P., Monmeneu, J. V., Amiguet, M., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.014254 · Cited by 93
Cardiac contractility modulation therapy in advanced systolic heart failure
Lyon, A. R., Samara, M. A., & Feldman, D. S. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.114 · Cited by 94
Anker, S. D., Karakas, M., Mentz, R. J., Ponikowski, P. P., Butler, J., Khan, M. S., Talha, K. M., Kalra, P. R., Hernandez, A. F., Mulder, H. S., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03671-1 · Cited by 121
Self-citationCardiac Cachexia: Perspectives for Prevention and Treatment
Okoshi, M. P., Capalbo, R. V., Romeiro, F. G., & Okoshi, K. (2016) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20160142 · Cited by 114
Absolute and functional iron deficiency in professional athletes during training and recovery
Reinke, S., Taylor, W. R., Duda, G. N., von Haehling, S., Reinke, P., Volk, H., Anker, S. D., & Doehner, W. (2010) · International Journal of Cardiology · doi:10.1016/j.ijcard.2010.10.139 · Cited by 106
Self-citationSelenium, Selenoproteins, and Heart Failure: Current Knowledge and Future Perspective
Al‐Mubarak, A. A., van der Meer, P., & Bömer, N. (2021) · Current Heart Failure Reports · doi:10.1007/s11897-021-00511-4 · Cited by 105
Nutritional Deficiency in Patients with Heart Failure
Sciatti, E., Lombardi, C., Ravera, A., Vizzardi, E., Bonadei, I., Carubelli, V., Gorga, E., & Metra, M. (2016) · Nutrients · doi:10.3390/nu8070442 · Cited by 88
Ferritin Levels and Risk of Heart Failure—the Atherosclerosis Risk in Communities Study
Silvestre, O. M., Gonçalves, A., Nadruz, W., Claggett, B. L., Couper, D. J., Eckfeldt, J. H., Pankow, J. S., Anker, S. D., & Solomon, S. D. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.701 · Cited by 92
Self-citation2020 Clinical practice guidelines for Chronic heart failure
Russian Society of Cardiology (2020) · Russian Journal of Cardiology · doi:10.15829/29/1560-4071-2020-4083 · Cited by 88
Kindermann, I., Fischer, D., Karbach, J., Link, A., Walenta, K., Barth, C., Ukena, C., Mahfoud, F., Köllner, V., Kindermann, M., et al. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs015 · Cited by 88
Management of Iron-Deficiency Anemia in Inflammatory Bowel Disease: A Systematic Review
Nielsen, O. H., Ainsworth, M., Coskun, M., & Weiss, G. (2015) · Medicine · doi:10.1097/md.0000000000000963 · Cited by 88
von Haehling, S., Anker, S. D., Doehner, W., Morley, J. E., & Vellas, B. J. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.07.068 · Cited by 96
Self-citationvon Haehling, S., Lainščak, M., Doehner, W., Ponikowski, P. P., Rosano, G. M. C., Jordan, J., Rozentryt, P., Rauchhaus, M., Karpov, R. S., Va, T., et al. (2010) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1007/s13539-010-0013-3 · Cited by 91
Self-citationToblli, J. E., Gennaro, F. D., & Rivas, C. (2015) · Heart Lung and Circulation · doi:10.1016/j.hlc.2014.12.161 · Cited by 98
Piednoir, P., Allou, N., Driss, F., Longrois, D., Philip, I., Beaumont, C., Montravers, P., & Lasocki, S. (2011) · European Journal of Anaesthesiology · doi:10.1097/eja.0b013e32834ad97b · Cited by 86
Iron and the heart: A paradigm shift from systemic to cardiomyocyte abnormalities
Paterek, A., Mackiewicz, U., & Ma̧czewski, M. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28820 · Cited by 91
“Serum ferritin in combination with transferrin saturation (TSAT) is also used to assess the body iron level in patients with acute phase response or chronic diseases, such as heart failure (HF; Anker et al., 2009).”
MethodBlumenstein, I., Shanbhag, S., Langguth, P., Kalra, P. A., Zoller, H., & Lim, W. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1912010 · Cited by 94
“life (Kansas City Cardiomyopathy Questionnaire [KCCQ]) [87,88].”
Hung, M., Ortmann, E., Besser, M. W., Martín-Cabrera, P., Richards, T., Ghosh, M., Bottrill, F. E., Collier, T. J., & Klein, A. A. (2014) · Heart · doi:10.1136/heartjnl-2014-305856 · Cited by 97
Intravenous Irons: From Basic Science to Clinical Practice
Bhandari, S., Pereira, D. I. A., Chappell, H. F., & Drakesmith, H. (2018) · Pharmaceuticals · doi:10.3390/ph11030082 · Cited by 99
“IV iron improves patient well-being and New York Heart Association (NYHA) functional class, as reported in the FAIR-HF trial (Ferinject Assessment in Patients with Iron Deficiency and Chronic Heart Failure) in both anaemic and non-anaemic patients and exercise capacity over 24 weeks in the CONFIRM-HF trial (Ferric Car…”
BackgroundBeyond the Cardiorenal Anaemia Syndrome: Recognizing the Role of Iron Deficiency
Macdougall, I. C., Canaud, B., de Francisco, A. L. M., Filippatos, G., Ponikowski, P., Silverberg, D., van Veldhuisen, D. J., & Anker, S. D. (2012) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfs056 · Cited by 84
Self-citationMyocardial iron homeostasis in advanced chronic heart failure patients
Leszek, P., Sochanowicz, B., Szperl, M., Kołsut, P., Brzóska, K., Piotrowski, W., Rywik, T. M., Danko, B., Polkowska–Motrenko, H., Różański, J., et al. (2011) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.08.006 · Cited by 96
Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis
Charytan, D. M., Pai, A. B., Chan, C. T., Coyne, D. W., Hung, A. M., Kovesdy, C. P., & Fishbane, S. N. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014090922 · Cited by 85
Aung, N., Ling, H. Z., Cheng, A. S. H., Aggarwal, S. K., Flint, J., Mendonça, M. M., Rashid, M., Kang, S., Weißert, S., COATS, C. J., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.12.091 · Cited by 84
van der Putten, K., Jie, K. E., van den Broek, D., Kraaijenhagen, R. J., Laarakkers, C., Swinkels, D. W., Braam, B., & Gaillard, C. A. (2010) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq099 · Cited by 82
Ghafourian, K., Shapiro, J. S., Goodman, L., & Ardehali, H. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.08.009 · Cited by 106
“FAIR-HF (Ferinject Assessment in Patients with Iron Deficiency and Chronic Heart Failure) (2009) was a double-blind, placebo-controlled RCT that enrolled 459 ambulatory HF patients in New York Heart Association (NYHA) functional class II (left ventricular ejection fraction [LVEF] #40%) or class III (LVEF #45%) (37).”
BackgroundInfluentialSierpinski, R., Josiak, K., Suchocki, T., Wojtas‐Polc, K., Mazur, G., Butrym, A., Rozentryt, P., van der Meer, P., Comin‐Colet, J., von Haehling, S., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2036 · Cited by 82
Self-citationFerreira, J. P., Anker, S. D., Butler, J., Filippatos, G. S., Iwata, T., Salsali, A., Zeller, C., Pocock, S., Zannad, F. M., & Packer, M. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2409 · Cited by 88
Self-citationIron Status and Survival in Diabetic Patients With Coronary Artery Disease
Ponikowska, B., Suchocki, T., Paleczny, B., Olesińska‐Mader, M., Powierza, S., Borodulin-Nadzieja, L., Reczuch, K. W., von Haehling, S., Doehner, W., Anker, S. D., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0528 · Cited by 90
Self-citationBaird-Gunning, J., & Bromley, J. (2016) · Australian Prescriber · doi:10.18773/austprescr.2016.069 · Cited by 83
Intravenous Iron Administration and Hypophosphatemia in Clinical Practice
Hardy, S., & Vandemergel, X. (2015) · International Journal of Rheumatology · doi:10.1155/2015/468675 · Cited by 81
Treatment of Anemia in Patients With Heart Disease: A Systematic Review
Kansagara, D. L., Dyer, E., Englander, H. L., Fu, R. F., Freeman, M., & Kagen, D. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-11-201312030-00007 · Cited by 89
Heme Levels Are Increased in Human Failing Hearts
Khechaduri, A., Bayeva, M., Chang, H.-C., & Ardehali, H. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.012 · Cited by 80
Täger, T., Hanholz, W., Cebola, R., Fröhlich, H., Franke, J., Doesch, A. O., Katus, H. A., Wians, F. H., & Frankenstein, L. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.06.035 · Cited by 90
Heart failure with preserved ejection fraction: current management and future strategies
Tschöpe, C., Birner, C. M., Böhm, M., Bruder, O., Frantz, S., Luchner, A., Maier, L. S., Störk, S., Kherad, B., & Laufs, U. (2017) · Clinical Research in Cardiology · doi:10.1007/s00392-017-1170-6 · Cited by 87
Contemporary pharmacological treatment and management of heart failure
Bozkurt, B. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-00997-0 · Cited by 96
“In patients with HFrEF and iron deficiency with or without anaemia, intravenous iron replacement is associated with improvements in quality of life, 6-min walking distance, exercise performance, NYHA class and HF symptoms 81–84 .”
Scrutinio, D., Passantino, A., Santoro, D., & Catanzaro, R. (2011) · European Journal of Heart Failure · doi:10.1093/eurjhf/hfq167 · Cited by 89
Medical therapy for chronic heart failure
Krum, H., & Teerlink, J. R. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61038-6 · Cited by 86
Anemia and acute coronary syndrome: current perspectives
Stucchi, M., Cantoni, S., Piccinelli, E., Savonitto, S., & Morici, N. (2018) · Vascular Health and Risk Management · doi:10.2147/vhrm.s140951 · Cited by 97
Anker, S. D., Friede, T., Butler, J., Talha, K. M., Placzek, M., Diek, M., Nosko, A., Stas, A., Kluge, S., Jarczak, D., et al. (2025) · JAMA · doi:10.1001/jama.2025.3833 · Cited by 91
Self-citationAnaemia, iron status, and gender predict the outcome in patients with chronic heart failure
Kurz*†, K., Lanser†, L., Seifert, M., Kocher, F., Pölzl, G., & Weiss*, G. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12755 · Cited by 77
Fernández‐Pombo, A., Rodríguez-Carnero, G., Castro, A. I., Cantón-Blanco, A., Seoane, L. M., Casanueva, F. F., Crujeiras, A. B., & Olmos, M. Á. M. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.07.027 · Cited by 88
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Tonelli, M. A., Berns, J. B., Bozkurt, B., Cheung, R. S., Cuevas, Y., Effa, E. E., Eisenga, M. F., Fishbane, S., Ginzburg, Y. Z., Haase, V. H., et al. (2026) · Kidney International · doi:10.1016/j.kint.2025.06.006 · Cited by 144
Nickol, A. H., Frise, M. C., Cheng, H.-Y., McGahey, A., McFadyen, B. M., Harris-Wright, T., Bart, N. K., Curtis, M. K., Khandwala, S., O'Neill, D. P., et al. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007911 · Cited by 76
Emans, M. E., Gaillard, S., Pfister, R., Tanck, M. W. T., Boekholdt, S. M., Wareham, N. J., & Khaw, K. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.05.002 · Cited by 86
Richards, T., Clevenger, B., Keidan, J., Collier, T. J., Klein, A. A., Anker, S. D., & Kelly, J. D. (2015) · Trials · doi:10.1186/s13063-015-0774-2 · Cited by 87
Self-citationKorean Guidelines for Diagnosis and Management of Chronic Heart Failure
Kim, M., Lee, J., Kim, E. J., Park, D.-G., Park, S., Park, J. J., Shin, M., Yoo, B., Youn, J., Lee, S. E., et al. (2017) · Korean Circulation Journal · doi:10.4070/kcj.2017.0009 · Cited by 81
Effectiveness of Preoperative Iron Supplementation in Major Surgical Patients With Iron Deficiency
Triphaus, C., Judd, L., Glaser, P., Goehring, M. H., Schmitt, E., Westphal, S., Füllenbach, C., Lindau, S., Zacharowski, K. D., Meybohm, P., et al. (2019) · Annals of Surgery · doi:10.1097/sla.0000000000003643 · Cited by 76
“ID was defined by laboratory results according to Munoz et al(12) and Anker et al.(13) Briefly, ferritin was <100 ng/mL and transferrin saturation <20%.”
BackgroundMethodInfluentialNot so benign haematology: anaemia of the elderly
Merchant, A. A., & Roy, C. N. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2011.08920.x · Cited by 76
Rational Management of Iron-Deficiency Anaemia in Inflammatory Bowel Disease
Nielsen, O., Soendergaard, C., Vikner, M., & Weiss, G. (2018) · Nutrients · doi:10.3390/nu10010082 · Cited by 76
Moliner, P., Jankowska, E. A., van Veldhuisen, D. J., Farre, N., Rozentryt, P., Enjuanes, C., Polonski, L., Meroño, O., Voors, A. A., Ponikowski, P., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.04.110 · Cited by 67
Hussain, I., Bhoyroo, J., Butcher, A., Koch, T. A., He, A., & Bregman, D. B. (2013) · Anemia · doi:10.1155/2013/169107 · Cited by 75
Heart Failure in the Last Year: Progress and Perspective
Tomasoni, D., Adamo, M., Anker, M. S., von Haehling, S., Coats, A. J. S., & Metra, M. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13124 · Cited by 102
Talboom, K., Borstlap, W. A. A., Roodbeen, S. X., Bruns, E. R. J., Buskens, C. J., Hompes, R., Tytgat, K. M. A. J., Tuynman, J. B., Consten, E. C. J., Heuff, G., et al. (2023) · The Lancet Haematology · doi:10.1016/s2352-3026(22)00402-1 · Cited by 75
Prevalence and Causes of Anemia in Hospitalized Patients: Impact on Diseases Outcome
Randi, M. L., Bertozzi, I., Santarossa, C., Cosi, E., Lucente, F., Bogoni, G., Biagetti, G., & Fabris, F. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9040950 · Cited by 90
Iron Deficiency in Heart Failure: A Scientific Statement from the Heart Failure Society of America
Beavers, C. J., Ambrosy, A. P., Butler, J., Davidson, B. T., Gale, S. E., Piña, I. L., Mastoris, I., Reza, N., Mentz, R. J., & Lewis, G. D. (2023) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2023.03.025 · Cited by 90
Doren, L. V., Steinheiser, M. M., Boykin, K., Taylor, K. J., Menendez, M., & Auerbach, M. (2024) · American Journal of Hematology · doi:10.1002/ajh.27220 · Cited by 99
Klip, I. T., Jankowska, E. A., Enjuanes, C., Voors, A. A., Banasiak, W., Bruguera, J., Rozentryt, P., Poloński, L., van Veldhuisen, D. J., Ponikowski, P. P., et al. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.84 · Cited by 81
Self-citationCardiorenal Syndrome and Heart Failure—Challenges and Opportunities
Yogasundaram, H., Chappell, M. C., Braam, B. G., & Oudit, G. Y. (2019) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2019.04.002 · Cited by 93
Iron deficiency, fatigue and muscle strength and function in older hospitalized patients
Neidlein, S., Wirth, R., & Pourhassan, M. (2020) · European Journal of Clinical Nutrition · doi:10.1038/s41430-020-00742-z · Cited by 85
Iron therapy in anaemic adults without chronic kidney disease
Gurusamy, K. S., Nagendran, M., Broadhurst, J., Anker, S. D., & Richards, T. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010640.pub2 · Cited by 79
Self-citationColet, J. C., Verdú-Rotellar, J. M., Vela, E., Clèries, M., Bustins, M., Mendoza, L., Badosa, N., Cladellas, M., Ferré, S., & Bruguera, J. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.12.005 · Cited by 87
Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure
Metra, M., Zacà, V., Parati, G., Agostoni, P., Bonadies, M., Ciccone, M. M., Dei, A., Iacoviello, M., Lagioia, R., Lombardi, C., et al. (2010) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0b013e32834058d1 · Cited by 83
Rineau, E., Chaudet, A., Chassier, C., Bizot, P., & Lasocki, S. (2016) · Transfusion · doi:10.1111/trf.13468 · Cited by 83
Clevenger, B., Gurusamy, K. S., Klein, A. A., Murphy, G. J., Anker, S. D., & Richards, T. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.514 · Cited by 78
Self-citationIron Deficiency and Red Cell Indices in Patients with Heart Failure
Tkaczyszyn, M., Colet, J. C., Voors, A. A., van Veldhuisen, D. J., Enjuanes, C., Moliner, P., Rozentryt, P., Poloński, L., Banasiak, W., Ponikowski, P. P., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.820 · Cited by 90
Self-citationAnemia associated with chronic heart failure: current concepts
Agarwal, A. K., & Shah (2013) · Clinical Interventions in Aging · doi:10.2147/cia.s27105 · Cited by 83
Intravenous Iron Exposure and Mortality in Patients on Hemodialysis
Miskulin, D. C., Tangri, N., Bandeen‐Roche, K., Zhou, J., McDermott, A., Meyer, K. B., Ephraim, P. L., Michels, W. M., Jaar, B. G., Crews, D. C., et al. (2014) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03370414 · Cited by 72
Iron deficiency anemia in older adults: A review
Joosten, E. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13194 · Cited by 86
Steinbeck, L., Ebner, N., Valentová, M., Bekfani, T., Elsner, S., Dahinden, P., Hettwer, S., Scherbakov, N., Schefold, J. C., Sandek, A., et al. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.400 · Cited by 76
Self-citationAnemia of cardiorenal syndrome
McCullough, P. A. (2021) · Kidney International Supplements · doi:10.1016/j.kisu.2020.12.001 · Cited by 81
“001), in patients with anemia (Hb #12 g/dl) and in the overall study population.(91) These improvements in iron parameters were accompanied by improvements in NYHA functional class, 6-minute walk tests, and QOL at 24 weeks.”
BackgroundMethodMitochondrial Iron Metabolism: The Crucial Actors in Diseases
Duan, G., Li, J., Duan, Y., Zheng, C., Guo, Q., Li, F., Zheng, J., Yu, J., Zhang, P., Wan, M., et al. (2022) · Molecules · doi:10.3390/molecules28010029 · Cited by 69
“Heart failure symptoms in the patient population can be improved by intravenous iron supplementation, which has been a recommended treatment for patients with heart failure with iron deficiency [79,80].”
BackgroundEnjuanes, C., Bruguera, J., Grau, M., Cladellas, M., González, G., Meroño, O., Moliner, P., Verdú-Rotellar, J. M., Farré, N., & Colet, J. C. (2015) · Revista Española de Cardiología · doi:10.1016/j.recesp.2015.08.017 · Cited by 74
Iron therapy for pre-operative anaemia
Ng, O., Keeler, B. D., Mishra, A., Simpson, A., Neal, K. R., Brookes, M., & Acheson, A. G. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011588.pub2 · Cited by 73
Paolillo, S., Scardovi, A. B., & Campodonico, J. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320960288 · Cited by 87
Iron Deficiency and Cardiovascular Disease: An Updated Review of the Evidence
Lapice, E., Masulli, M., & Vaccaro, O. (2013) · Current Atherosclerosis Reports · doi:10.1007/s11883-013-0358-0 · Cited by 78
Preoperative anemia-screening clinics
Lin, Y. (2019) · Hematology · doi:10.1182/hematology.2019000061 · Cited by 79
Becher, P. M., Schrage, B., Benson, L., Fudim, M., Cabrera, C. C., Dahlström, U., Rosano, G. M. C., Jankowska, E. A., Anker, S. D., Lund, L. H., et al. (2021) · European Journal of Heart Failure · doi:10.1002/ejhf.2338 · Cited by 74
Self-citationMyocardial Iron Deficiency and Mitochondrial Dysfunction in Advanced Heart Failure in Humans
Zhang, H., Jamieson, K. L., Grenier, J. G., Nikhanj, A., Tang, Z., Wang, F., Wang, S., Seidman, J. G., Seidman, C. E., Thompson, R. B., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.022853 · Cited by 81
“10,56 Thus, iron status should be assessed in symptomatic patients with HF both with or without anemia, and treatment of iron deficiency warrants consideration in clinical practice.”
Metadata
- Authors
- Anker, S. D., Comin Colet, J., Filippatos, G., Willenheimer, R., Dickstein, K., Drexler, H., Lüscher, T. F., Bart, B., Banasiak, W., Niegowska, J., Kirwan, B.-A., Mori, C., von Eisenhart Rothe, B., Pocock, S. J., Poole-Wilson, P. A., & Ponikowski, P.
- Affiliations
- Stavanger University Hospital (NO)
- Lund University (SE)
- University of Bergen (NO)
- Medizinische Hochschule Hannover (DE)
- University Hospital Zurich (CH)
- Pirogov Russian National Research Medical University (RU)
- State Oil Company of Azerbaijan Republic (Azerbaijan) (AZ)
- Vifor Pharma (Switzerland) (CH)
- London School of Hygiene & Tropical Medicine (GB)
- Imperial College London (GB)
- Wroclaw Medical University (PL)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-12-17
- Volume
- 361
- Issue
- 25
- Pages
- 2436-2448
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2148669301
- Cited by
- 2,083
- References
- 26
- Citations by year
- 2026: 101 · 2025: 131 · 2024: 145 · 2023: 156 · 2022: 162 · 2021: 190 · 2020: 128 · 2019: 129 · 2018: 113 · 2017: 133 · 2016: 101 · 2015: 115 · 2014: 102 · 2013: 93 · 2012: 106
- FWCI
- 62.22
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- ABACUS. Repositorio de Producción Científica (Universidad Europea) (submittedVersion, other-oa)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (submittedVersion, public-domain)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, other-oa)
- Lund University Publications (Lund University) (submittedVersion, other-oa)
- University of Bedfordshire Repository (University of Bedfordshire) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Amgen
- Teva Pharmaceutical Industries
- Vifor Pharma
- Servier
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
- Keywords
- ferric carboxymaltose, intravenous iron, chronic heart failure, iron deficiency, anemia, reduced left ventricular ejection fraction, NYHA functional class, symptom improvement, functional capacity, 6-minute walk test, health-related quality of life, ferritin, transferrin saturation, adverse events, mortality, serious adverse events, iron deficiency anemia
- MeSH terms
- Iron Deficiencies, Aged, Chronic Disease, Female, Ferric Compounds, Ferritins, Follow-Up Studies, Heart Failure, Hematinics, Humans, Male, Maltose, Quality of Life, Stroke Volume, Ventricular Dysfunction, Left, Anemia, Iron-Deficiency
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.